Business
Germany’s BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialised in mRNA technology with...
Hi, what are you looking for?
Germany’s BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialised in mRNA technology with...
Moderna said it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19.
Pfizer and BioNTech have begun a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine.
People who received BioNTech's coronavirus vaccine had ten times the amount of antibodies than those given China's Sinovac.
The largest real-world study yet of the Pfizer/BioNTec vaccine confirmed that the jab provided more than 95 percent protection against Covid-19.
Europe’s medicines regulator said Tuesday it would decide by December 29 whether to grant emergency approval to a Covid-19 vaccine developed by Germany’s BioNTech...
An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday,...
BioNTech co-founder Ugur Sahin said on Thursday the frontrunner Covid-19 vaccine his German firm is developing with Pfizer could be rolled out before the...
Progress on a Covid-19 vaccine has propelled the modest husband-and-wife team behind German firm BioNTech into the global limelight, with attention inevitably focussing on...